Carl Zeiss Meditec AGMEX:AFXN 68 EV-to-FCF is 8.98 as of Jun. 24, 2026, which is 78% below its 10-year median of 40.66. GuruFocus rates MEX:AFXN with a GF Score™ of 68/100 and a GF Value™ of MXN8,900.18. The stock has 4 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 81.82% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Carl Zeiss Meditec AG's Enterprise Value is MXN49,123 Mil.
Carl Zeiss Meditec AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was MXN5,468 Mil. Therefore, Carl Zeiss Meditec AG's EV-to-FCF for today is 8.98.
The historical rank and industry rank for Carl Zeiss Meditec AG's EV-to-FCF or its related term are showing as below:
MEX:AFXN'
s EV-to-FCF Range Over the Past 10 Years
Min: -2795.01 Med: 40.66 Max: 274.95
Current: 9.79
During the past 13 years, the highest EV-to-FCF of Carl Zeiss Meditec AG was 274.95. The lowest was -2795.01. And the median was 40.66.
MEX:AFXN's EV-to-FCF is ranked better than 81.82% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.66
vs MEX:AFXN: 9.79
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carl Zeiss Meditec AG (MEX:AFXN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Carl Zeiss Meditec AG's PE Ratio (TTM) for today is calculated as:
Carl Zeiss Meditec AG's share price for today is MXN3258.20.
Carl Zeiss Meditec AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN29.915.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's EV-to-FCF falls into.
Carl Zeiss Meditec AG's current Enterprise Value is MXN49,123 Mil.
Carl Zeiss Meditec AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,468 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (MEX:AFXN) has a EV-to-FCF of 8.98 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Carl Zeiss Meditec AG and its competitors. This is 78% below median its historical median of 40.66. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #76 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 18.2%.
Is Carl Zeiss Meditec AG's EV-to-FCF too high?
Carl Zeiss Meditec AG's current EV-to-FCF of 8.98 is 78% below median its 10-year median of 40.66. The Medical Devices & Instruments industry median EV-to-FCF is 22.66. Carl Zeiss Meditec AG's value of 8.98 is 60.4% below this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #76 out of 418 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Carl Zeiss Meditec AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #76 out of 418 companies for EV-to-FCF. This places Carl Zeiss Meditec AG in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.66. Carl Zeiss Meditec AG's value of 8.98 is 60.4% below this benchmark. While the company's 10-year median is 40.66 vs. the industry median of 22.66, Carl Zeiss Meditec AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.66, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current EV-to-FCF of 8.98 is 60.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current EV-to-FCF is 8.98, which is 78% below median its own 10-year median of 40.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (MEX:AFXN) has a current EV-to-FCF of 8.98. The stock's GF Value™ is MXN8,900.18, compared to a current price of MXN3,258.20 — trading 63.4% below its estimated fair value. The current EV-to-FCF is 8.98, which is 78% below median its 10-year median of 40.66 and 60.4% below the Medical Devices & Instruments industry median of 22.66. Carl Zeiss Meditec AG's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Carl Zeiss Meditec AG (MEX:AFXN), the current EV-to-FCF is 8.98 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (MEX:AFXN) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of MXN3,258.20 is trading 63.4% below its estimated GF Value™ of MXN8,900.18.
Key valuation signals for MEX:AFXN:
EV-to-FCF: 8.98 (78% below median its 10-year median of 40.66)
GF Value™: MXN8,900.18 vs. price of MXN3,258.20 (63.4% below fair value)
Industry Position: 60.4% below the Medical Devices & Instruments median (#76 of 418)
No single metric tells the full story. See the MEX:AFXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
68GF Score
Get the complete analysis for MEX:AFXN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AFXN has been successfully added to your 
